During the past decade, R&H Clinical Research conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "R&H Clinical Research" #1 sponsor was "Lipocine Inc." with 2 trials, followed by "Adamis Pharmaceuticals Corporation" with 1 trials sponsored, "Axcella Health, Inc" with 1 trials sponsored, "Ionis Pharmaceuticals, Inc." with 1 trials sponsored and "Neurana Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

According to Clinical.Site data, the most researched conditions in "R&H Clinical Research" are "Covid19" (2 trials), "Acute Pain" (1 trials), "Back Muscle Spasm" (1 trials), "Back Pain" (1 trials) and "Back Spasm Upper" (1 trials). Many other conditions were trialed in "R&H Clinical Research" in a lesser frequency.

Most popular intervention types in "R&H Clinical Research" are "Drug" (7 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "AXA1125" (1 trials), "Bucillamine" (1 trials), "ION224" (1 trials) and "LPCN 1144" (1 trials). Other intervention names were less common.

The vast majority of trials in "R&H Clinical Research" are 6 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "R&H Clinical Research". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 2 completed trials in R&H Clinical Research, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in R&H Clinical Research, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".